RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
NAICS 541711
Total Obligations
$18.26B
Total Awards
473
States
0
Last Updated
Mar 26, 2026
Top 50 Awards in RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Largest individual obligations in NAICS 541711.
| Award | Recipient | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|---|
CONT_AWD_DEAC3608GO28308_8900_-NONE-_-NONE- MODIFICATION NUMBER 1490 PROVIDES TOTAL FUNDING IN THE AMOUNT OF $1,667,500.00. THIS INCLUDES APPROPRIATED FUNDING IN THE AMOUNT OF $1,667,500.00 AND IS REPORTED IN FPDS-NG, THE R… | ALLIANCE FOR ENERGY INNOVATION, LLC Colorado | Department of Energy Department of Energy | — | LAKEWOOD, CO-07 | 2024 | $10,301,736,516 |
CONT_AWD_HHSO100201600030C_7505_-NONE-_-NONE- EO14042 EMERGENT AV7909 ANTHRAX VACCINE | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $1,385,742,139 |
CONT_IDV_HHSO100201700018C_7505 EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL MODIFICATION TO DESCOPE WORK AND DEOBLIGATE FUNDS. | JANSSEN PHARMACEUTICALS, INC. New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $919,512,953 |
CONT_AWD_HHSO100201700016C_7505_-NONE-_-NONE- NO COST MOD TO REVISE THE CONTRACT SECTIONS: ARTICLE B.2.1., ARTICLE C.1., ARTICLE F.4, , ARTICLE G.4. AND THE STATEMENT OF WORK. | REGENERON PHARMACEUTICALS INC New York | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | TARRYTOWN, NY-17 | 2024 | $693,056,927 |
CONT_AWD_HHSO100201700020C_7505_-NONE-_-NONE- NO COST MODIFICATION TO REVISE THE JOINT OVERSIGHT COMMITTEE MEMBERS AND EXTEND THE PERIOD OF PERFORMANCE FOR CLIN 0001 TO SEPT 25, 2027. | REGENERON PHARMACEUTICALS INC New York | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | TARRYTOWN, NY-17 | 2024 | $611,318,728 |
CONT_IDV_HSHQDC15C00064_7001 MODIFICATION TO REALIGN FUNDING ON CLINS 8202 AND 8302 | BATTELLE NATIONAL BIODEFENSE INSTITUTE, LLC Maryland | Department of Homeland Security Office of Procurement Operations | — | — | 2024 | $329,628,151 |
CONT_AWD_HHSO100201700012C_7505_-NONE-_-NONE- MERCK - EBOLA ZAIRE VACCINE EXERCISE AND FUND OPTION 6 IN ORDER TO CONTINUE TO MEET THE REQUIREMENT OF MAINTAINING 1.13 MILLION DOSES OF ERVEBO. | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | WHITEHOUSE STATION, NJ-07 | 2024 | $236,307,634 |
CONT_IDV_HHSO100201300011C_7505 THE PURPOSE OF THIS AGREEMENT MODIFICATION IS ADD LAURA SADDISON AS A NON-VOTING JOC MEMBER AT NO ADDITIONAL COST TO THE GOVERNMENT. | GLAXOSMITHKLINE, LLC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $215,851,503 |
CONT_AWD_HHSO100201600009C_7505_-NONE-_-NONE- THE PURPOSE OF THIS NO COST MODIFICATION IS TO ADMINISTRATIVELY CORRECT THE CONTRACT CLINS PERIOD OF PERFORMANCE IN THE PRISM CONTRACT WRITING SYSTEM IN ORDER TO ALIGN IT FOR INVO… | CERUS CORPORATION California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | CONCORD, CA-10 | 2024 | $185,466,764 |
CONT_AWD_HHSO100201600038C_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS TO UPDATE COST SHARE AMOUNT AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002. | HOFFMANN-LA ROCHE INC. New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | LITTLE FALLS, NJ-11 | 2024 | $157,343,419 |
CONT_AWD_HHSN272201600013C_7529_-NONE-_-NONE- MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) | AMERICAN TYPE CULTURE COLLECTION Virginia | Department of Health and Human Services National Institutes of Health | — | MANASSAS, VA-10 | 2024 | $140,973,859 |
CONT_AWD_HHSO100201000026C_7505_-NONE-_-NONE- ELUSYS 0026C MOD#1 9 DE-OB CANCELLING FUNDS | ELUSYS THERAPEUTICS INC New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | PINE BROOK, NJ-11 | 2024 | $138,258,202 |
CONT_AWD_HHSO100201700013C_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE STATEMENT OF WORK TO PROVIDE ADDITIONAL INFORMATION | JANSSEN VACCINES & PREVENTION B.V. | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $132,282,550 |
CONT_AWD_W911QY13C0056_9700_-NONE-_-NONE- EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 12 MARCH 2026 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS. | DYNPORT VACCINE COMPANY LLC Maryland | Department of Defense Department of the Army | — | FREDERICK, MD-06 | 2024 | $117,632,941 |
CONT_AWD_HHSO100201500035C_7505_-NONE-_-NONE- THERMAL BURN DEBRIDEMENT LICENSURE, APPROVAL AND CLEARANCE OF PRODUCT THROUGH THE FDA | MEDIWOUND LTD | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $117,518,418 |
CONT_AWD_HHSO100201600002C_7505_-NONE-_-NONE- ADVANCED DEVELOPMENT OF CEFTOBIPROLE | BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $110,632,461 |
CONT_AWD_HHSO100201600026C_7505_-NONE-_-NONE- ADD THE DEFINITION OF "DISCONTINUED PROGRAM" TO SECTION 1.B; ADD LANGUAGE TO THE "ORAVANCE PROGRAM" DEFINITION THAT STATES THE REMOVAL OF FURTHER PROGRESSION OF S-743229 FROM THE… | MEDICINES COMPANY, THE New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | PARSIPPANY, NJ-11 | 2024 | $98,144,230 |
CONT_AWD_HHSN272201400008C_7529_-NONE-_-NONE- NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI New York | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-13 | 2024 | $79,763,886 |
CONT_IDV_HHSO100201500010C_7505 THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE $2,863,538.00 FROM CONTRACT HHSO100201500010C. POP ENDED ON 5/21/2024. | GLAXOSMITHKLINE, LLC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $78,310,394 |
CONT_AWD_HHSO100201500027C_7505_-NONE-_-NONE- EO14042 - CELL BASED SKIN SUBS FOR DEFINITIVE CARE OF BURN INJURIES | STRATATECH CORPORATION Wisconsin | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | MADISON, WI-02 | 2024 | $74,851,753 |
CONT_AWD_75A50120F33002_7505_HHSO100201400002I_7505 CRO ASSISTANCE FOR THE ACTIV-1 MASTER PROTOCOL | TECHNICAL RESOURCES INTERNATIONAL, INC. Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | BETHESDA, MD-08 | 2024 | $74,513,740 |
CONT_AWD_HHSO100201600029C_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE FUNDING IN THE AMOUNT OF $6,336.92 IN CANCELLING FUNDS FROM CLIN 0001. | MODERNATX, INC. Massachusetts | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | CAMBRIDGE, MA-07 | 2024 | $72,965,186 |
CONT_AWD_HHSO100201500029C_7505_-NONE-_-NONE- THE PURPOSE OF MODIFICATION P00013 IS TO DE-OBLIGATE CANCELING FUNDS | PFIZER INC New York | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $69,739,002 |
CONT_AWD_HHSO100201600031C_7505_-NONE-_-NONE- MODIFICATION P00007 THIS MODIFICATION IS BEING ISSUED TO DE-OBLIGATE CANCELLING FUNDS IN THE AMOUNT OF $235,502.00. | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | AMES, IA-04 | 2025 | $65,103,309 |
CONT_IDV_HHSO100201100034C_7505 THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO DE-OBLIGATE CANCELING FUNDS FROM REQUISITION OS212728 OF $282,172.97, UPDATE SECTION F.2. DELIVERABLES, AND G.5. INVOICES/FINANCIN… | ELUSYS THERAPEUTICS INC New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $62,146,948 |
CONT_IDV_HHSO100201700014C_7505 THE PURPOSE OF THIS BILATERAL MODIFICATION DE-OBLIGATES CANCELING FUNDS FROM REQUISITION OS250781 IN THE AMOUNT OF -$3,174,640.95 FROM CLIN0005, UPDATES SECTIONS G.1 CONTRACTING O… | SUMMIT (OXFORD) LIMITED | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2025 | $59,203,413 |
CONT_AWD_HHSN275201700002C_7529_-NONE-_-NONE- DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT | THE EMMES COMPANY, LLC Maryland | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $55,340,350 |
CONT_AWD_HHSO100201500008C_7505_-NONE-_-NONE- NO COST MODIFICATION TO CLOSEOUT THE CONTRACT IN ITS ENTIRETY. | JANSSEN VACCINES & PREVENTION B.V. | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $48,930,332 |
CONT_AWD_HHSN272201600029C_7529_-NONE-_-NONE- THE PURPOSE OF THIS CONTRACT IS THE DEVELOPMENT OF A NOVEL ORALLY BIOAVAILABLE BETA-LACTAMASE INHIBITOR THROUGH DELIVERY TO THE GOVERNMENT OF: CMC AND PRELIMINARY NON-CLINICAL DEV… | VENATORX PHARMACEUTICALS INC Pennsylvania | Department of Health and Human Services National Institutes of Health | — | MALVERN, PA-06 | 2024 | $48,773,739 |
CONT_AWD_HHSO100201500004C_7505_-NONE-_-NONE- ADVANCED DEVELOPMENT OF NUTHRAX (ANTHRAX VACCINE ABSORBED WITH CPG 7909) OR AV7909 | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $43,794,113 |
CONT_AWD_HHSO100201600017C_7505_-NONE-_-NONE- DNAE / PATHOGEN IDENTIFICATION FROM SPECIMEN, VIA CAPTURE, EXTRACTION AND SEQUENCING (PISCES) | DNAE GROUP HOLDINGS LIMITED | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $43,409,723 |
CONT_AWD_HHSN273200800005C_7529_-NONE-_-NONE- NTP/NIEHS ARCHIVES AND REPOSITORY MANAGEMENT AND SUPPORT | EXPERIMENTAL PATHOLOGY LABORATORIES, INC. Virginia | Department of Health and Human Services National Institutes of Health | — | DURHAM, NC-04 | 2025 | $41,581,952 |
CONT_AWD_HHSO100201500028C_7505_-NONE-_-NONE- AUTOGRAFT-SPARING PRODUCTS FOR DEFINITIVE CARE OF BURN INJURIES | AVITA MEDICAL AMERICAS, LLC California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | NORTHRIDGE, CA-32 | 2024 | $40,800,433 |
CONT_AWD_HHSN272200800044C_7529_-NONE-_-NONE- TO DE-OBLIGATE REMAINING FUNDS AND ADMINISTRATIVELY CLOSE THE CONTRACT. | FISHER BIOSERVICES INC Maryland | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $40,769,875 |
CONT_AWD_HHSO100201500021C_7505_-NONE-_-NONE- THE PURPOSE OF THIS BILATERAL ADMINISTRATIVE MODIFICATION IS TO CHANGE THE KEY PERSONNEL AND ADD AN ALTERNATE COR. 1. CHANGE ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR… | POLYNOVO BIOMATERIALS PTY LTD | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $38,882,504 |
CONT_AWD_HHSN272201400004C_7529_-NONE-_-NONE- EO14042: NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) | EMORY UNIVERSITY Georgia | Department of Health and Human Services National Institutes of Health | — | ATLANTA, GA-05 | 2024 | $38,463,167 |
CONT_AWD_HHSN272201400005C_7529_-NONE-_-NONE- NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). | UNIVERSITY OF ROCHESTER New York | Department of Health and Human Services National Institutes of Health | — | ROCHESTER, NY-25 | 2024 | $37,729,389 |
CONT_AWD_W81XWH11C0516_9700_-NONE-_-NONE- CLINICAL TRIAL SUPPORT SERVICES FOR WRAIR | ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. Ohio | Department of Defense Department of the Army | — | SILVER SPRING, MD-08 | 2024 | $35,222,551 |
CONT_IDV_HHSO100201500013C_7505 DE-OBLIGATE FISCAL YEAR 2024 CANCELING FUNDS. | REGENERON PHARMACEUTICALS INC New York | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $33,135,560 |
CONT_AWD_HHSO100201700001C_7505_-NONE-_-NONE- PUT A STOP TO TASKS THAT ARE NO LONGER NEEDED | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $32,952,759 |
CONT_AWD_HHSO100201600008C_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS TO CLOSE THIS CONTRACT IN LINE WITH FAR 4.804 | ALTIMMUNE, INC. Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $29,928,823 |
CONT_AWD_HHSN272201200022C_7529_-NONE-_-NONE- AIDS REAGENT PROGRAM (ARP) | FISHER BIOSERVICES INC Maryland | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $29,421,403 |
CONT_AWD_HHSN272201600028C_7529_-NONE-_-NONE- THE PURPOSE OF THIS CONTRACT IS TO DEVELOP A MONOCLONAL ANTIBODY (MAB) AV-1 AS A SAFE INJECTABLE THERAPEUTIC. | ABVIRO LLC Maryland | Department of Health and Human Services National Institutes of Health | — | BETHESDA, MD-08 | 2024 | $29,175,011 |
CONT_AWD_HHSN272201400007C_7529_-NONE-_-NONE- TO DE-OBLIGATE REMAINING FUNDS AND ADMINISTRATIVELY CLOSE THE CONTRACT. | THE JOHNS HOPKINS UNIVERSITY Maryland | Department of Health and Human Services National Institutes of Health | — | BALTIMORE, MD-07 | 2024 | $27,856,129 |
CONT_AWD_HHSN271201100013C_7529_-NONE-_-NONE- MEDICINAL CHEMISTRY FOR NEUROTHERAPEUTICS PROGRAM | CURIA GLOBAL INC New York | Department of Health and Human Services National Institutes of Health | — | ALBANY, NY-20 | 2024 | $27,277,165 |
CONT_AWD_HHSN272201200004C_7529_-NONE-_-NONE- NIAID DAIT CLINICAL SITE MONITORING CENTER | PPD DEVELOPMENT LP North Carolina | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2025 | $27,247,204 |
CONT_AWD_W81XWH20F0253_9700_W81XWH16D0009_9700 CONTRACTOR-ACQUIRED PROPERTY (CAP) AND GOVERNMENT FURNISHED EQUIPMENT | INBIOS INTERNATIONAL INC Washington | Department of Defense Defense Health Agency | — | SEATTLE, WA-07 | 2024 | $25,655,995 |
CONT_IDV_HHSO100201700030C_7505 DE-OBLIGATE REMAINING FUNDS AND CLOSEOUT THE AWARD. | SRI INTERNATIONAL California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2026 | $25,540,532 |
CONT_AWD_HHSN272201400028C_7529_-NONE-_-NONE- BIOINFORMATIC RESOURCE CENTERS FOR INFECTIOUS DISEASES | PERATON INC. Virginia | Department of Health and Human Services National Institutes of Health | — | MCLEAN, VA-11 | 2024 | $23,385,247 |
CONT_AWD_W81XWH15C0048_9700_-NONE-_-NONE- FREEZE DRIED PLASMA CLINICAL TRIAL FOR BLA RESUBMISSION. | WESTAT, INC. Maryland | Department of Defense Defense Health Agency | — | ROCKVILLE, MD-08 | 2024 | $22,748,424 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Source: USAspending.gov · All Industries